Last reviewed · How we verify

Aspirin + Acid folic — Competitive Intelligence Brief

Aspirin + Acid folic (Aspirin + Acid folic) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antiplatelet agent + vitamin supplement. Area: Cardiovascular.

phase 3 Antiplatelet agent + vitamin supplement COX-1 (aspirin); folate metabolism pathway (folic acid) Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

Aspirin + Acid folic (Aspirin + Acid folic) — Assistance Publique - Hôpitaux de Paris. Aspirin inhibits platelet aggregation via COX inhibition while folic acid supports cellular methylation and DNA synthesis.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Aspirin + Acid folic TARGET Aspirin + Acid folic Assistance Publique - Hôpitaux de Paris phase 3 Antiplatelet agent + vitamin supplement COX-1 (aspirin); folate metabolism pathway (folic acid)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antiplatelet agent + vitamin supplement class)

  1. Assistance Publique - Hôpitaux de Paris · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Aspirin + Acid folic — Competitive Intelligence Brief. https://druglandscape.com/ci/aspirin-acid-folic. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators: